rs1126642
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002055.5(GFAP):c.883G>A(p.Asp295Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0421 in 1,613,504 control chromosomes in the GnomAD database, including 1,847 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.036 ( 152 hom., cov: 33)
Exomes 𝑓: 0.043 ( 1695 hom. )
Consequence
GFAP
NM_002055.5 missense
NM_002055.5 missense
Scores
4
9
5
Clinical Significance
Conservation
PhyloP100: 6.17
Publications
24 publications found
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
- Alexander diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Alexander disease type IIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003569454).
BP6
Variant 17-44911695-C-T is Benign according to our data. Variant chr17-44911695-C-T is described in ClinVar as Benign. ClinVar VariationId is 66509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFAP | NM_002055.5 | c.883G>A | p.Asp295Asn | missense_variant | Exon 5 of 9 | ENST00000588735.3 | NP_002046.1 | |
| GFAP | NM_001363846.2 | c.883G>A | p.Asp295Asn | missense_variant | Exon 5 of 10 | NP_001350775.1 | ||
| GFAP | NM_001242376.3 | c.883G>A | p.Asp295Asn | missense_variant | Exon 5 of 7 | NP_001229305.1 | ||
| GFAP | NM_001131019.3 | c.883G>A | p.Asp295Asn | missense_variant | Exon 5 of 8 | NP_001124491.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GFAP | ENST00000588735.3 | c.883G>A | p.Asp295Asn | missense_variant | Exon 5 of 9 | 1 | NM_002055.5 | ENSP00000466598.2 |
Frequencies
GnomAD3 genomes AF: 0.0356 AC: 5419AN: 152234Hom.: 147 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
5419
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0454 AC: 11291AN: 248574 AF XY: 0.0458 show subpopulations
GnomAD2 exomes
AF:
AC:
11291
AN:
248574
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0428 AC: 62509AN: 1461152Hom.: 1695 Cov.: 33 AF XY: 0.0428 AC XY: 31148AN XY: 726966 show subpopulations
GnomAD4 exome
AF:
AC:
62509
AN:
1461152
Hom.:
Cov.:
33
AF XY:
AC XY:
31148
AN XY:
726966
show subpopulations
African (AFR)
AF:
AC:
663
AN:
33476
American (AMR)
AF:
AC:
1915
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
1184
AN:
26106
East Asian (EAS)
AF:
AC:
5848
AN:
39686
South Asian (SAS)
AF:
AC:
4885
AN:
86236
European-Finnish (FIN)
AF:
AC:
768
AN:
52992
Middle Eastern (MID)
AF:
AC:
120
AN:
5740
European-Non Finnish (NFE)
AF:
AC:
44585
AN:
1111830
Other (OTH)
AF:
AC:
2541
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
3525
7051
10576
14102
17627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1802
3604
5406
7208
9010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0356 AC: 5428AN: 152352Hom.: 152 Cov.: 33 AF XY: 0.0349 AC XY: 2603AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
5428
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
2603
AN XY:
74498
show subpopulations
African (AFR)
AF:
AC:
926
AN:
41590
American (AMR)
AF:
AC:
437
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
166
AN:
3470
East Asian (EAS)
AF:
AC:
731
AN:
5178
South Asian (SAS)
AF:
AC:
289
AN:
4830
European-Finnish (FIN)
AF:
AC:
149
AN:
10626
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2677
AN:
68032
Other (OTH)
AF:
AC:
50
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
276
552
829
1105
1381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
159
ALSPAC
AF:
AC:
171
ESP6500AA
AF:
AC:
98
ESP6500EA
AF:
AC:
324
ExAC
AF:
AC:
5422
Asia WGS
AF:
AC:
331
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5Other:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;.;.;.;.;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.;.;M;M;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D;.;D;.;.;.
REVEL
Uncertain
Sift
Pathogenic
.;.;D;.;D;.;.;.
Sift4G
Pathogenic
.;.;D;.;D;.;D;.
Polyphen
0.99
.;D;.;.;.;.;.;.
Vest4
0.36, 0.39, 0.21
MPC
1.2
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.